Canada markets closed

Canntab Therapeutics Limited (TBF1.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.4820+0.0200 (+4.33%)
At close: 8:00AM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2020-05-31
2019-05-31
2018-05-31
2017-12-31
Total Revenue
843.375
133.334
239.999
26.667
0
Operating Expenses
Research Development
14.479
105.746
128.144
140.732
-
Selling General and Administrative
2,743
2,339
2,437
2,258
188.001
Total Operating Expenses
3,221
2,749
2,742
2,450
188.001
Operating Income or Loss
-2,954
-2,616
-2,502
-2,423
-188.001
Total Other Income/Expenses Net
-
-
-
-
5.554
Income Before Tax
-2,989
-2,607
-2,459
-2,408
-182.447
Income from Continuing Operations
-2,989
-2,607
-2,459
-2,408
-182.447
Net Income
-2,989
-2,607
-2,459
-2,408
-182.447
Net Income available to common shareholders
-2,989
-2,607
-2,459
-2,408
-182.447
Basic EPS
-
-0.10
-0.10
-0.11
-0.40
Diluted EPS
-
-0.10
-0.10
-0.11
-0.40
Basic Average Shares
-
27,169
25,299
21,129
556.339
Diluted Average Shares
-
27,169
25,299
21,129
556.339
EBITDA
-
-2,320
-2,421
-2,372
-188.001